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Corticosteroid-binding globulin (CBG) is a high-affinity plasma protein that transports glucocorticoids and progesterone. Oth-
ers and we have reported non-synonymous single nucleotide polymorphisms (SNPs) that influence CBG production or ster-
oid-binding activity. However, no promoter polymorphisms affecting the transcription of human CBG gene (Cbg) have been 
reported. In the present study we investigated function implications of six promoter SNPs, including 26 C/G, 54 C/T, 144 
G/C, 161 A/G, 205 C/A, and 443/444 AG/, five of which are located within the first 205 base pairs of 5′-flanking region 
and close to the highly conserved footprinted elements, TATA-box, or CCAAT-box. Luciferase reporter assays demonstrated 
that basal activity of the promoter carrying 54 T or 161 G was significantly enhanced. The first three polymorphisms, 26 
C/G, 54 C/T, and 144 G/C located close to the putative hepatic nuclear factor (HNF) 1 binding elements, altered the transac-
tivation effect of HNF1. We also found a negative promoter response to dexamethasone-activated glucocorticoid receptor 
(GR) , although none of the SNPs affected its transrepression function. Our results suggest that human Cbg 26 C/G, 54 
C/T, 144 G/C, and 161 A/G promoter polymorphisms alter transcriptional activity, and further studies are awaited to explore 
their association with physiological and pathological conditions. 
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Corticosteroid-binding globulin (CBG) is a steroid-binding 
protein that transports glucocorticoids and progesterone in 
the blood [1]. The human CBG gene (SERPINA6, Cbg) re-
sides on chromosome 14q32.1 within a cluster of related 
serine proteinase inhibitor (SERPIN) genes [2]. However, 
unlike other serpins, CBG lacks proteinase inhibitor activity 
[3]. CBG binds with high affinities the circulating glucocor-
ticoids [4] and progesterone [5], both of which are 
well-known hormones for pregnancy maintenance or labor 
onset. While CBG mainly binds >80% of cortisol in human 
peripheral blood [3], at the maternal-fetal interface CBG 
will be occupied by the very high concentrations of proges-
terone, which is several fold higher than those of cortisol [6]. 
In the circulation of women during mid-late pregnancy, 
approximately 10% of CBG steroid-binding sites are occu-
pied by progesterone, versus <1% in non-pregnant women 
[5]. Plasma CBG levels rise progressively through gestation 
until term pregnancy [7], and so do blood cortisol and pro-
gesterone levels. Maternal plasma CBG, total and free cor-
tisol concentrations are reduced in pre-eclampsia and gesta-
tional hypertension patients, and this may be a consequence 
of decreased Cbg synthesis driven by cytokines or increased 
degradation driven by inflammation [7].  
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Besides its role in systemic transport of glucocorticoids 
and progesterone, CBG also plays direct roles in their local 
delivery, thereby modulating their access to target tissues 
[8]. Except for the liver, the main organ where CBG is syn-
thesized, CBG is also expressed in fetal exocrine pancreas 
and the proximal convoluted tubules of postnatally devel-
oping kidney, where CBG may influence their glucocorti-
coid-dependent maturation [9,10]. The release of ligands 
from CBG at their sites of action is controlled in a targeted 
manner, as illustrated by crystal structure studies [1]. The 
best example for this is at sites of inflammation neutrophil 
elastase cleaves CBG at a single site in a surface exposed 
reactive center loop, which causes a significant rearrange-
ment in the tertiary structure of CBG that disrupts ster-
oid-binding, thus providing a highly efficient mechanism 
for the local release of cortisol [11–13]. As there is evidence 
that CBG is the target of other proteinases [9], CBG accu-
mulated at the maternal-fetal interface [6] can be cleaved by 
placenta-specific proteinases and thus involved in regulating 
local progesterone bioavailability and action.  
Thus far, seven non-synonymous single nucleotide pol-
ymorphisms (SNPs) within the SERPINA6 sequence, in-
cluding CBG W11Stop, CBG Santiago, A51V, L93H, CBG 
Lyon, G237V, and E102G, have been identified that influ-
ence CBG production [14–16] or its cortisol-binding activi-
ty [16–19]. Among these, all the variants are considered 
rare except for recently reported CBG A51V by us [16], 
which occurs at a frequency of ~1:37 in Han Chinese and 
will allow clinical consequences of CBG deficiencies to be 
assessed in large populations. However, to our knowledge, 
relatively little is known regarding the gene regulatory 
mechanism of Cbg, and the SNPs in the promoter region 
that might affect Cbg transcription have not been reported. 
The proximal rat Cbg promoter which is located within 
295 base pair (bp) has been cloned, and DNase I foot-
printing experiment has identified five cis-acting ele-
ments/footprinted (FP) regions (FP1 to FP5), which are 
highly conserved in the human Cbg promoter [20]. Regions 
FP1 to FP5 resemble recognition sequences for hepatocyte 
nuclear factor 1 (HNF1), transcription factor CP-2 (TFCP2), 
D site of albumin promoter (albumin D-box) binding pro-
tein (DBP), HNF3 and CCAAT-enhancer-binding protein 
(C/EBP), respectively, and electrophoretic mobility shift 
assays (EMSAs) indicate that the FP1 element binds HNF1 
[20,21]. Nucleotide (nt) 295 to 52 is a positive compo-
nent of rat Cbg transcriptional activity, whereas sequences 
located between nt 295 and 800 repress transcription, and 
this repressor effect is partially overcome by the addition of 
sequences up to 1200 [20]. 
Genome-wide sequencing projects (http://www.ncbi.nlm. 
nih.gov/snp) have identified several single nucleotide pol-
ymorphisms (SNPs) in the proximal human Cbg promoter. 
The SNPs involved in this study include C/G SNP at 26 bp 
(rs188371806), C/T SNP at 54 bp (rs115833113), G/C 
SNP at 144 bp (rs180685032), A/G SNP at 161 bp 
(rs186384700), C/A SNP at 205 bp (rs77990214), and 
AG/ SNP at 443/444 bp (rs80219741 and rs77992119). 
In order to determine whether these SNPs affect human Cbg 
gene transcription, a series of plasmids containing the fire-
fly luciferase gene under the control of various human Cbg 
promoter fragments (phCbg) were constructed, binding of 
transcription factors that these SNPs may affect were pre-
dicted by using TESS (Transcription Element Search System, 
http://www.cbil.upenn.edu/cgi-bin/tess/tess), Genomatix/  
MatInspector (http://www.genomatix.de/) and ConSite (http:// 
asp.ii.uib.no:8090/cgi-bin/CONSITE/consite/), and effects 
of these SNPs on the basal promoter activity and regulation 
of Cbg transcription were investigated.  
1  Materials and methods 
1.1  Cell culture 
The human hepatoblastoma cell line HepG2 was a generous 
gift from Prof. Geoffrey L. Hammond (Department of Ob-
stetrics and Gynecology, University of British Columbia, 
and Child and Family Research Institute). HepG2 cells were 
grown in DMEM medium supplemented with 10% fetal 
bovine serum (FBS), 100 U penicillin mL1 and 100 μg 
streptomycin mL1 at 37°C in a 5% CO2 atmosphere. 
1.2  Constructs 
Expression plasmids for human HNF1 [22] and HNF1 [23], 
in pcDNA3.1/HisC and pcDNA3.1/HisB, respectively, were 
generous gifts from Dr. Lise Bjørkhaug and Dr. Pål Rasmus 
Njølstad (University of Bergen, Norway). Expression plas-
mids of human c-Jun and c-Fos were kind gifts from Dr. 
John E. Coligan (NIAID, National Institutes of Health, 
USA). Human specificity protein 1 (Sp1) expression plas-
mid was generously provided by Dr. Guntram Suske (Insti-
tute of Molecular Biology and Tumor Research, Germany). 
Expression vectors of glucocorticoid receptor (GR)  and , 
pRShGR and pRShGRand an empty vector pRSV were 
from Dr. Ronald M. Evans (Salk Institute for Biological 
Studies, USA). Coding sequences of nuclear factor [24] -IC 
and -YA were PCR-cloned and inserted into pcDNA3 ex-
pression vector. All the constructs were sequenced to con-
firm their authenticities. 
1.3  Cloning of 5′-flanking regions of the human Cbg 
promoter into firefly luciferase reporter vector 
Different 5′-flanking regions (291, 501, 833, or 1347) 
of the human Cbg promoter upstream of the transcription 
start site (+1) extending to part of non-coding exon I (+54) 
were obtained by PCR from HepG2 genomic DNA using 
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the primers (phCbg291for/501for/833for/1347for as 
forward primers and phCbgrev as the reverse primer) shown 
in Table 1. Among these, the 291 to +54 construct corre-
sponds to the proximal human Cbg promoter, which in-
cludes the five footprinted region [20]. The PCR products 
were subcloned into Xho I-Hind III sites of the pGL3-basic 
luciferase reporter vector. All constructs were sequenced to 
confirm their authenticity. 
1.4  Site-directed mutagenesis 
To obtain the human Cbg promoter reporter plasmids that 
carry different SNPs (26C/G, 54C/T, 144G/C, 161A/G, 
205C/A, 443/444AG/), appropriate plasmids were 
subjected to site-directed mutagenesis using the Quik-
Change® Lightning Site-Directed Mutagenesis Kit (catalog 
No. 200516; Stratagene). The forward (for) and reverse (rev) 
primers for mutagenesis are listed in Table 1. All constructs 
were sequenced to confirm that only the targeted mutations 
had occurred. 
1.5  Luciferase assay 
About 1×106 cells/well were seeded in six-well plates to 
reach 50%–60% confluence one day before transfection. 
Cells were co-transfected with 2 μg reporter plasmid and 
100 ng Renilla luciferase reporter vector or 300 ng 
pCMVlacZ control plasmid (in the case when Renilla lucif-
erase activity changed upon co-transfection with other tran-
scription factors or administration of dexamethasone) [25] 
per well using QuickShuttle transfection reagents (catalog 
No. KX0110041; Beijing Kang Bi Quan Biotech. Co. Ltd.), 
according to the manufacturer’s instructions. For transacti-
vation or transrepression experiments, 200 ng expression 
vectors for transcription factors or the corresponding empty 
vectors were co-transfected. Dexamethasone (100 nmol L1) 
treatment was performed together with co-transfection of 
GR plasmids, with ethanol as the vehicle control. 48 h after 
transfection, the cells were washed three times with cold 
PBS buffer and harvested by scraping and centrifuging at 
5000 r min1 for 3 min. The cell pellets were re-suspended 
in 150 L lysis buffer and lysed by two cycles of freezing 
and thawing. The activities of firefly and Renilla luciferases 
were measured using Dual-Luciferase® Reporter Assay 
System (catalog No. E1960; Promega), according to the 
manufacturer’s instructions. The -galactosidase activities 
were determined by OD reading at 405 nmol L1. The fire-
fly luciferase activity was normalized by the activity of Re-
nilla luciferase or -galactosidase.  
1.6  Statistics  
Data were analyzed using Student’s t-test, and results were 
expressed as the means±SD. P-values of <0.05 were con-
sidered significant. 
2  Results 
2.1  Phylogenetic analysis of the human Cbg proximal 
promoter 
The human Cbg (NC_000014.8)) and mouse Cbg 
(NC_000078.6) proximal promoters from 500 bp upstream 
of the transcription start site were compared with the rat 
Cbg (NC_005105.3) promoter containing the five foot-
printed regions (FP1-FP5) [20]. In the rat and human Cbg 
promoter, two perfectly conserved elements before the  
Table 1  Primer sequences used for PCR amplificationa) 
Primer Sequence (5′–3′) 
phCbg 291for CGGCTCGAGCAAGTATCTGCACCTTGGTGC 
phCbg 501for CGGCTCGAGACTTCCATGCAGCTCAGTTTCC 
phCbg 833for CGGCTCGAGCCAGAGCTACTGTGGCCACAT 
phCbg 1347for CCGCTCGAGCAGGACTTATCAAAGGGAG 













a) Characters underlined represent mutagenesis sites. 
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transcription start site, ATTTA and CCACT, are suggested 
as a TATA-box and CCAAT-box, respectively [20,26]. As 
shown in Figure 1, the five footprinted regions, TATA-box, 
and CCAAT-box are highly conserved in the human, rat, 
and mouse Cbg promoters. Moreover, the human, rat, and 
mouse Cbg promoters are highly conserved from approxi-
mately 300 bp relative to the transcription start site to the 
non-coding exon I, which supports that the rat Cbg promot-
er from the first 295 bp of the 5′-flanking region encom-
passing the five footprinted regions has the most efficient 
promoter activity [20]. 
2.2  Cloning and identification of human Cbg promoter 
We cloned a series of the human Cbg promoter fragments 
encompassing different 5'-flanking regions, 291, 501, 
833, or 1347 bp relative to the transcription start site (+1), 
and to +54 bp in non-coding exon I (Figure 2A), into the 
firefly luciferase reporter plasmid pGL3-basic. As shown in 
Figure 2A, the proximal phCbg located within the first 291 
bp of the 5′-flanking region, which includes the FP1 to FP5 
regions, had a strong activity. Extending the promoter re-




Figure 1  Phylogenetic comparison of the mouse, rat, and human Cbg proximal promoter sequences and location of SNPs in the human Cbg promoter. The 
mouse Cbg promoter from 500 to +33 bp (NC_000078.6), the rat Cbg promoter from 500 to +48 bp (NC_005105.3), and the human Cbg promoter from 
500 to +82 bp (NC_000014.8) relative to the transcription start site (+1, in lowercase lettering) are aligned using ClustalW (http://www.ebi.ac.uk/ 
Tools/msa/clustalw2/). The positions of the SNPs in the human Cbg promoter investigated in the present study, including 26 bp C/G (rs188371806), 54 bp 
C/T (rs115833113), 144 bp G/C (rs180685032), 161 bp A/G (rs186384700), 205 bp C/A (rs77990214), and 443/-444 bp AG/ (rs80219741 and 
rs77992119), are denoted as empty boxes. DNase I footprinted regions (FP1–FP5) previously identified within the rat Cbg promoter [20] are illustrated by 
bold and underlined letters. Sequences that resemble TATA- and CCAAT-box motifs are shown in bold and italic fonts. Putative HNF1 binding  
elements in the human Cbg promoter are marked in shaded boxes. 
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Figure 2  Functional comparison of human Cbg promoters with different SNPs in their basal promoter activities. A, Activities of different-length human 
Cbg promoters fused into pGL3-basic, including 291 to +54 bp (291/+54), 501 to +54 bp (501/+54), 833 to +54 bp (833/+54), 1347 to +54 bp 
(1347/+54), relative to the transcription start site. B, Promoter reporter plasmid (phCbg291/+54, closed bars) was subjected to site-directed mutagenesis to 
introduce different SNPs (26 C/G, 54 C/T, 144 G/C, 161 A/G, and 205 C/A), phCbg501/+54 (open bars) was mutated to delete the AG SNP 
(443/444 AG/), and their promoter activities were examined in parallel. phCbg, promoter of human Cbg. The transcriptional potentials are indicated as 
relative firefly luciferase activities normalized by corresponding Renilla luciferase activities. Data points are shown as mean±SD of three independent  
experiments. *, P<0.05 as compared to unmutated phCbg291/+54. 
activity that was again overcome by further inclusion of 
sequences present in phCbg833 and phCbg1347. Thus, 
unlike rat Cbg promoter pCbg295, which is the most active 
construct [20], the human Cbg promoter phCbg833/+54 
represented the most positive component of Cbg transcrip-
tional activity. However, the activity of phCbg291/+54 
was comparable to that of phCbg833/+54 and therefore 
still supports that the most active promoter resides within 
the region encompassing the five footprinted regions, i.e., 
cis-regulatory elements. 
2.3  54 C/T and 161 A/G SNP affected the basal hu-
man Cbg promoter activity 
The SNPs in the human Cbg promoter investigated in the 
present study include C/G SNP at 26 bp (close to the 
TATA-box ), C/T SNP at 54 bp (located beside FP1 and 
CCAAT-box), G/C SNP at 144 bp (located in the middle 
of FP3), A/G SNP at 161 bp (located beside FP3), C/A 
SNP at 205 bp (located between FP4 and FP5), and AG/ 
SNP at 443/444 bp, the locations of which are shown in 
Figure 1. By site-directed mutagenesis, we introduced each 
individual SNP into the proximal human Cbg promoter. To 
minimize the effects of upstream repressor or enhancer se-
quences, all the proximal SNPs, including 26 C/G, 54 
C/T, 144 G/C, 161 A/G, 205 C/A, were introduced into 
phCbg291/+54, and 443/444 AG nucleotides were re-
moved on top of phCbg501/+54. Functional analysis of 
different human Cbg promoters showed that the promoter 
with 54 T or 161 G caused a nearly two- to three-fold 
induction in their basal promoter activities (Figure 2B). The 
changes caused by other SNPs were less than two-fold and 
therefore were not considered significant (Figure 2B). 
2.4  HNF1 and HNF1 had distinct effects on the 
transcription of the human Cbg gene and promoter 
SNPs alter HNF1 response 
Sequence of the proximal human Cbg promoter was 
searched in the databases for putative transcription factor 
binding elements, and three regions with a high degree of 
identity to known HNF1 consensus element (5′-GGTTA- 
ATNATTAA/CA/C) [27,28] were revealed. The sequence in 
FP1 is perfectly conserved in human, rat and mouse Cbg 
promoters and it contains the HNF1 consensus element 
(TCTAACCATTAACC) with deviations at only two posi-
tions (Figure 1). It has been previously demonstrated by 
EMSA experiments that in the rat Cbg promoter FP1 binds 
HNF1 [20,21]. The other two putative HNF1 binding sites 
were found in FP2 and part of FP3 (Figure 1).  
To explore the functional impact of the two HNF1 
isoforms, HNF1 and HNF1 homodimers or heterodimers, 
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on the human Cbg gene transcription, we co-transfected 
human Cbg promoter reporter plasmid along with HNF1 
and HNF1 expression plasmids individually or together. 
As shown in Figure 3, the human Cbg proximal promoter 
with the C SNP at 26 bp (Figure 3A, closed bars), the C 
SNP at 54 bp (Figure 3B, closed bars), or the G SNP at 
144 bp (Figure 3C, closed bars), was significantly activat-
ed in response to over-expressed HNF1 by at least 
two-fold. However, when HNF1 was over-expressed, only 
a slight response was detected in the above promoters (Fig-
ure 3, closed bars). Co-expression of HNF1 with HNF1 
was not additive to transcriptional activation (Figure 3, 
closed bars). Therefore, HNF1 and HNF1 had different 
effects on the transcription of the human Cbg gene. 
As 26 C/G, 54 C/T, and 144 G/C are the first three 
proximal SNPs located close to HNF1 binding element in  
 
 
Figure 3  Effects of SNPs, 26 C/G (panel A), 54 C/T (panel B), or 144 G/C (panel C), on the transcriptional activation of the human Cbg proximal 
promoter (phCbg291/+54) by over-expressed HNF1 homodimers, HNF1 homodimers, or HNF1and HNF1 heterodimers. A, Response of the human 
Cbg proximal promoter with the 26 C (closed bars) or G (open bars) SNP to over-expressed HNF1. B, Response of the human Cbg proximal promoter with 
the 54 C (closed bars) or T (open bars) SNP to over-expressed HNF1. C, Response of the human Cbg proximal promoter with the 144 G (closed bars) or 
C (open bars) SNP to over-expressed HNF1. Human Cbg proximal promoter plasmid was co-transfected with pcDNA3.1() empty vector (control), HNF1 
or/and HNF1 expression plasmids with the amounts described in Material and methods. Normalized transcriptional activities by -galactosidase activities 
are indicated as relative luciferase activities. Each bar represents mean±SD of three parallel experiments. *, P<0.05 as compared to the corresponding  
co-transfection with empty vector. 
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FP1 and FP3 (Figure 1), we introduced these three individ-
ual SNPs into the human proximal promoter phCbg291/ 
+54, which carried the G SNP at 26 bp (Figure 3A, open 
bars), the T SNP at 54 bp (Figure 3B, open bars), or the C 
SNP at 144bp (Figure 3C, open bars). While the introduc-
tion of the above SNPs into the promoter did not alter the 
transactivation effect of HNF1 or HNF1&HNF1 heter-
odimer, they all caused a gain of HNF1 response by about 
two-fold (Figure 3, open bars). 
2.5  GR and GR had distinct effects on the tran-
scription of the human Cbg gene 
It has been previously demonstrated that glucocorticoids 
repress Cbg transcription in the livers of adult rats [29]. 
Searching in the database suggested that 161 A/G, 205 
C/A, or 443/444 AG/ might affect the binding of GR, 
although no consensus glucocorticoid response elements 
within the proximal promoter were found. As shown in 
Figure 4, the human Cbg promoter (phCbg291/+54) with 
the A SNP at 161 bp (Figure 4A, closed bars), the C SNP 
at 205 bp (Figure 4B, closed bars), or phCbg501/+54 
with the AG SNP at 443/444 bp (Figure 4C, closed bars), 
was abundantly repressed by over-expressed GRin com-
plex with dexamethasone, but not by inactivated GR alone 
(Figure 4, closed bars). Neither GR nor dexamethasone-       
GR complexhad an effect on promoter activity (Figure 4, 
closed bars). We next introduced the above three SNPs into 
phCbg291/+54, which carried the G SNP at 161 bp (Fig-
ure 4A, open bars), the A SNP at 205 bp (Figure 4B, open 
bars), or phCbg501/+54 with the AG SNP deleted at 
443/444 bp (Figure 4C, open bars). However, the results 
showed no changes in the promoter response to over-      
expressed GR or GR in complex with dexamethasone 
(Figure 4, open bars)
2.6  Promoter responses to transcription factors NF-IC, 
NF-YA, Sp1, activator protein 1 (AP1) were not affected 
by the SNPs presented in this study 
The database also predicted NF-IC, NF-YA, Sp1, and AP1 
as transcription factors that might be affected. NF-IC, but 
not NF-YA, had a negative effect on the proximal promoter 
activity. Sp1 and c-Jun had a transactivation effect. Howev-
er, none of the SNPs tested, including 54 C/T, 144 G/C, 
161 A/G, 205 C/A, 443/444 AG/, affected the pro-
moter activities in response to these transcription factors 
(data not shown).
3  Discussion 
Proteolysis of CBG by neutrophil elastase serves to be the 
mechanism of rapid and targeted delivery of biologically 
active steroids to their sites of action [1]. Apart from prote-
olytic cleavage, hepatic biosynthesis of Cbg reduces con-
siderably during acute inflammation, due to an interleukin-6 
(IL-6) induced decrease in Cbg mRNA stability [30]. Dex-
amethasone-induced decreases in plasma CBG levels in 
adult rats have been attributed to decreased Cbg transcrip-
tion in the liver [29]. In the present study, we firstly set out 
to investigate the functional effects of six proximal promot-
er SNPs (26 C/G, 54 C/T, 144 G/C, 161 A/G, 205 
C/A, 443/444 AG/), five of which are located within the 
first 205 bp of the 5′-flanking region, on the transcriptional 
control of human Cbg. 
Cis-acting sequence elements, i.e., footprinted regions 
FP1 to FP5, in the rat Cbg promoter have been identified 
[20]. These FP1-FP5 sites, TATA-box, and CCAAT-box 
are highly conserved in the human, rat, and mouse Cbg 
promoters. Consistent with the rat Cbg promoter encom-
passing FP1 to FP5, which is the most active construct [20], 
the human proximal Cbg promoter including the FP1 to FP5 
was also among the most active constructs tested. An 
EMSA and an antibody-supershifting EMSA have proved 
that FP1 element binds HNF1 [20,21], and FP2 to FP5 have 
been suggested to resemble recognition sequences for 
TFCP2, DBP, HNF3 and C/EBP, respectively [20]. Our 
results demonstrated that the introduction of two promoter 
SNPs, the 54 T SNP and 161 G SNP, significantly en-
hanced the basal promoter activity, as compared to 54 C 
SNP and 161 A SNP. These data are not unexpected be-
cause 54 C/T SNP is located beside FP1 and the 
CCAAT-box [20,26] and 161 A/G SNP is located beside 
FP3 and the putative HNF1 binding site. As previously re-
ported, mutations within rat FP1, which prevent HNF1 
binding, do not influence the basal transcriptional activity of 
rat Cbg [21]. However, this does not mean FP1 or HNF1 is 
not important for transcriptional control, because different 
physiological conditions will drive the expression and mod-
ulate the DNA motif binding of HNF1, a major determinant 
of the transcription regulation of a number of hepatic genes, 
such as 1-antitrypsin, fibrinogen, albumin, C-reactive pro-
tein (CRP), and -fetoprotein (AFP) [31–33].  
HNF1 and HNF1, two members of the HNF1 tran-
scription factor family, share amino-terminal dimerization 
domain and POU-like DNA-binding homeo domain, but not 
carboxyl-terminal transcriptional activation domain, and 
they bind DNA as homodimers or heterodimers [24,34,35]. 
Our data demonstrated that in the human Cbg proximal 
promoter, HNF1 or HNF1 had different effect on the 
basal promoter activity. The proximal human Cbg promoter 
phCbg291/+54 was significantly activated by over-       
expressed HNF1, and 26 C/G, 54 C/T, and 144 G/C 
polymorphisms did not affect its transactivating function. 
On the contrary, 26 G, 54 T, and 144 C all probably 
created an HNF1 binding site, because the promoter 
phCbg291/+54 with 26 C, 54 C, or 144 G was not  
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Figure 4  Effects of SNPs, 161 A/G (panel A), 205 C/A (panel B), or 443/444 AG/ (panel C), on the transcriptional regulation of the human Cbg 
proximal promoter by over-expressed GR or GRwith or without the administration of synthetic glucocorticoid (dexamethasone, DEX). A, Response of 
the human Cbg proximal promoter (phCbg291/+54) with the 161 A (closed bars) or G (open bars) SNP to over-expressed GR with/without DEX. B, Re-
sponse of the human Cbg proximal promoter (phCbg291/+54) with the 205 C (closed bars) or A (open bars) SNP to over-expressed GR with/without DEX. 
C, Response of the human Cbg proximal promoter (phCbg501/+54) with the 443/444 AG (closed bars) or these two nucleotides deleted (open bars) to 
over-expressed GR with/without DEX. Human Cbg proximal promoter plasmid was co-transfected with pRSV empty vector (control), GRα or GR expres-
sion plasmids (pRShGR or pRShGR) with the amounts described in Material and methods. Normalized transcriptional activities by -galactosidase activi-
ties are indicated as relative luciferase activities. Each bar represents mean±SD of three parallel experiments. *, P<0.05 as compared to the corresponding  
co-transfection with empty vector.
significantly stimulated by over-expressed HNF1 whereas 
their counterparts gained an abundant response. This is also 
expected because 26 C/G and 54 C/T are all close to FP1, 
the most important cis-regulatory element identified in rat 
Cbg that binds HNF1 [20], especially HNF1 [21], and 
144 G/C is located within the putative HNF1 binding ele-
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ment and FP3. Taken together with previously discussed 
54 C/T and 161 A/G which affected basal promoter ac-
tivity, the first four polymorphisms located within the first 
~160 bp in 5′-flanking region either affect basal transcrip-
tion activity or HNF1 transactivation. Moreover, our data 
demonstrated no functional effect of HNF1 on HNF1- 
stimulated promoter activity, as previously reported by oth-
ers [36–38]. Therefore, the significant in vivo reduction of 
CBG biosynthesis during inflammation is likely associated 
with decreased binding activity of HNF1 to Cbg promoter 
and subsequently decreased gene transcription initiation, 
and promoter SNPs might be associated with different in-
flammatory response among different individuals.  
Accumulated evidence from both in vivo and in vitro ex-
periments has linked CBG synthesis to the regulation by 
glucocorticoids. Research in different adult species has  
illustrated that administration of synthetic glucocorticoid 
dexamethasone exerts inhibitory effects on hepatic Cbg 
biosynthesis at the transcriptional level [29,39,40]. However, 
earlier predictive study within rat Cbg proximal promoter 
failed to reveal any glucocorticoid response element (GRE) 
[20]. Glucocorticoids act by binding to GR. In the absence 
of glucocorticoids, GR is maintained in the cytoplasm. 
When the GR binds to glucocorticoid, the activated gluco-
corticoid-GR complex enters into the nucleus and modu-
lates gene transcription. It is becoming widely recognized 
that in contrast to “simple” GRE [41], which is a transacti-
vation element, no consensus sequence for GREs that con-
fer transcriptional repression has emerged, i.e., this ‘‘teth-
ering’’ GRE does not contain DNA binding sites for GR, 
but instead contains binding sites for other transcription 
factors that GR can interact with [42]. In this respect, the 
non-existence of consensus GRE in the human Cbg pro-
moter does not rule out the transrepressive activity of GR, 
especially because a research using GR-knockout mice re-
vealed that GR is essential for repressing Cbg gene expres-
sion in the liver, and for dexamethasone-inhibited CBG 
expression in the adult liver [39]. We therefore performed 
Cbg promoter activity study in response to activated dexa-
methasone-GR or -GR complex. The results showed that 
activated GRbut not GRcaused significant transrepres-
sion effects on the activities of the human Cbg promoters, 
phCbg291/+54 and phCbg501/+54, although none of the 
SNPs, 161 A/G, 205 C/A, or 443/444 AG/, altered 
the response to activated GR. Whether this is physiologi-
cally or pathologically relevant, for instance pregnancy 
maintenance, labor onset or pregnancy-related disease 
pre-eclampsia, remains to be further elucidated. Further-
more, in the absence of GR overexpression, neither of the 
human Cbg promoters was responsive to dexamethasone in 
human hepatoma HepG2 cells, which express endogenous 
GR [43,44]. However, in the presence of overexpressed 
GRdexamethasone treatment inhibited Cbg promoter 
activity. Similar effects have also been reported on the 
promoter activity of many other genes, such as sterol 
27-hydroxylase (CYP27A1) [45], CYP2C19 [46], UDP-        
glycosyltransferase 1A6 (UGT1A6) [47] and UGT1A1 [48] 
in HepG2 cells. Therefore, the level of endogenous GR, 
which could be activated by dexamethasone and subse-
quently translocated into the nucleus, was insufficient for 
exerting a transrepression effect on human Cbg promoter, 
and this could be overcome by complementation with a GR 
expression vector. 
In summary, by utilizing luciferase reporter assay we 
demonstrated that the promoter with 54 T or 161 G pol-
ymorphisms, which are located beside the CCAAT-box/FP1 
and FP3, respectively, significantly enhanced the basal 
promoter activities. 26 C/G, 54 C/T, and 144 G/C pol-
ymorphisms altered the transactivation effect of HNF1. A 
negative response of human Cbg promoter to dexame-
thasone-activated GRwasfound, but none of the SNPs, 
161 A/G, 205 C/A, or 443/444 AG/, affected the 
transrepression effect of GR. Further association studies 
are needed to explore whether the first four proximal pro-
moter SNPs that alter Cbg transcription activities, including 
26 C/G, 54 C/T, 144 G/C, 161 A/G, are related to 
physiological and pathological conditions. 
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